These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17547263)

  • 1. A basic guide to understanding plasma B-type natriuretic peptide in the diagnosis of congestive heart failure.
    Kreiger G
    Medsurg Nurs; 2007 Apr; 16(2):75-8; quiz 79. PubMed ID: 17547263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is B-type natriuretic peptide-guided heart failure management cost-effective?
    Morimoto T; Hayashino Y; Shimbo T; Izumi T; Fukui T
    Int J Cardiol; 2004 Aug; 96(2):177-81. PubMed ID: 15262031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of b-type natriuretic peptide in heart failure management.
    Newton PJ; Betihavas V; Macdonald P
    Aust Crit Care; 2009 Aug; 22(3):117-23. PubMed ID: 19589695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain natriuretic peptide in diagnosis and treatment of heart failure.
    Bhatia V; Nayyar P; Dhindsa S
    J Postgrad Med; 2003; 49(2):182-5. PubMed ID: 12867703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical value of rapid assay for plasma B-type natriuretic peptide in differentiating congestive heart failure from pulmonary causes of dyspnoea.
    Zhao SQ; Hu YM; Li Q; Liu XR; Wang M; Zhang WY; Wu T; Nie XL; Zhao N; Wang LR
    Int J Clin Pract; 2008 Feb; 62(2):214-20. PubMed ID: 18081799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-type natriuretic peptides for the diagnosis of congestive heart failure in dyspneic oldest-old patients.
    Chenevier-Gobeaux C; Delerme S; Allo JC; Arthaud M; Claessens YE; Ekindjian OG; Riou B; Ray P
    Clin Biochem; 2008 Sep; 41(13):1049-54. PubMed ID: 18573245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-type natriuretic peptide for diagnosis of heart failure in emergency department patients: a critical appraisal.
    Schwam E
    Acad Emerg Med; 2004 Jun; 11(6):686-91. PubMed ID: 15175210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnosis of acute dyspnea: the value of B natriuretic peptides in the emergency department.
    Ray P; Delerme S; Jourdain P; Chenevier-Gobeaux C
    QJM; 2008 Nov; 101(11):831-43. PubMed ID: 18664534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does bnp testing aid diagnosis of heart failure?
    Drug Ther Bull; 2009 Oct; 47(10):110-3. PubMed ID: 19809084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic impact of brain natriuretic peptide in cardiac and noncardiac diseases.
    Zakynthinos E; Kiropoulos T; Gourgoulianis K; Filippatos G
    Heart Lung; 2008; 37(4):275-85. PubMed ID: 18620103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
    Behnes M; Brueckmann M; Ahmad-Nejad P; Lang S; Wolpert C; Elmas E; Kaelsch T; Gruettner J; Weiss C; Borggrefe M; Neumaier M
    Int J Cardiol; 2009 Jun; 135(2):165-74. PubMed ID: 18603317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nurses' performance in classifying heart failure patients based on physical exam: comparison with cardiologist's physical exam and levels of N-terminal pro-B-type natriuretic peptide.
    Sauer J; Rabelo ER; Castro RA; Goldraich L; Rohde LE; Clausell N; Beck-da-Silva L
    J Clin Nurs; 2010 Dec; 19(23-24):3381-9. PubMed ID: 20964749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
    Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R
    J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjusting for clinical covariates improves the ability of B-type natriuretic peptide to distinguish cardiac from non-cardiac dyspnoea: a sub-study of HEARD-IT.
    Kevin Rogers R; Stehlik J; Stoddard GJ; Greene T; Collins SP; Peacock WF; Maisel AD; Clopton P; Michaels AD
    Eur J Heart Fail; 2009 Nov; 11(11):1043-9. PubMed ID: 19812054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in heart failure management.
    Isaac DL
    Curr Opin Cardiol; 2008 Mar; 23(2):127-33. PubMed ID: 18303525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoterminal brain-type natriuretic peptide levels correlate with heart failure in patients with bidirectional Glenn anastomosis and with morbidity after the Fontan operation.
    Lechner E; Schreier-Lechner EM; Hofer A; Gitter R; Mair R; Biebl A; Tulzer G
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):560-4. PubMed ID: 19698835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
    Fox PR; Oyama MA; Reynolds C; Rush JE; DeFrancesco TC; Keene BW; Atkins CE; Macdonald KA; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Nguyenba TP; Lehmkuhl LB; Lefbom BK; Moise NS; Hogan DF
    J Vet Cardiol; 2009 May; 11 Suppl 1():S51-61. PubMed ID: 19394287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement.
    Antonini-Canterin F; Popescu BA; Popescu AC; Beladan CC; Korcova R; Piazza R; Cappelletti P; Rubin D; Cassin M; Faggiano P; Nicolosi GL
    Int J Cardiol; 2008 Aug; 128(3):406-12. PubMed ID: 17662495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.